An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent

Insights

Thyroid hormones impact key enzymes in obese mice differently. Specifically, the obese (ob/ob) mouse lacks a thyroid-dependent sodium- and potassium-dependent ATPase, explaining its metabolic abnormalities.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Biochemistry

Background:

  • Obesity is associated with altered metabolic pathways and hormonal regulation.
  • Thyroid hormones play a crucial role in regulating energy metabolism and enzyme activity.
  • Understanding enzymatic differences in obesity models is key to identifying therapeutic targets.

Purpose of the Study:

  • To investigate the impact of thyroid status on key metabolic enzymes in different models of obesity.
  • To elucidate the role of specific enzymes, such as glycerol 3-phosphate dehydrogenase and (Na⁺ + K⁺)-ATPase, in the pathogenesis of obesity.
  • To determine if abnormalities in thyroid hormone-responsive enzymes contribute to the metabolic phenotype of genetically obese (ob/ob) mice.

Main Methods:

  • Comparative analysis of enzyme activities in liver and kidney tissues from lean, gold thioglucose-induced obese, and genetically obese (ob/ob) mice.
  • Experimental manipulation of thyroid status: euthyroid, induced hypothyroidism, and triiodothyronine treatment.
  • Assay of glycerol 3-phosphate dehydrogenase, ouabain-suppressible sodium- and potassium-dependent ATPase, and adenylate cyclase activities.

Main Results:

  • Glycerol 3-phosphate dehydrogenase activity was reduced in hypothyroidism and increased with triiodothyronine in all groups.
  • Lean and gold thioglucose-obese mice showed increased (Na⁺ + K⁺)-ATPase activity with triiodothyronine and decreased activity with hypothyroidism.
  • Obese (ob/ob) mice exhibited a lack of thyroid hormone-dependent increase in (Na⁺ + K⁺)-ATPase activity, which remained low.

Conclusions:

  • The impaired response of (Na⁺ + K⁺)-ATPase to thyroid hormones in obese (ob/ob) mice is a significant finding.
  • This enzymatic deficit in obese (ob/ob) mice may underlie their characteristic metabolic abnormalities.
  • Adenylate cyclase activity was similar across groups and unaffected by thyroid hormones, suggesting a specific role for ATPase dysfunction.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...